Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.20 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON

: eCTD Composition for 3.2.S.1 - JSON Representation

Raw json | Download

{
  "resourceType" : "Composition",
  "id" : "260f5aa3-23d2-4999-8e5f-70f247390ee5",
  "meta" : {
    "profile" : [
      🔗 "http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-32s10"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Composition</b><a name=\"260f5aa3-23d2-4999-8e5f-70f247390ee5\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Composition &quot;260f5aa3-23d2-4999-8e5f-70f247390ee5&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ectd-composition-32s10.html\">eCTD Substance General Information</a></p></div><p><b>identifier</b>: Substance General - levoThyroxine</p><p><b>status</b>: final</p><p><b>type</b>: Substance General Information <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-pqcmc-comp-section-types.html\">Code System PQCMC Comp Section Types</a>#32S10)</span></p><p><b>date</b>: 2023-12-15 22:19:47+0000</p><p><b>author</b>: <a href=\"Bundle-30536c0e-456c-4f90-9f02-da7be1d289e9.html#urn-uuid-b69435a0-45c6-4d44-9fde-b354e17408d7\">urn:uuid:b69435a0-45c6-4d44-9fde-b354e17408d7</a></p><p><b>title</b>: eCTD Substance General Information for levoThyroxine</p></div>"
  },
  "identifier" : [
    {
      "value" : "Substance General - levoThyroxine"
    }
  ],
  "status" : "final",
  "type" : {
    "coding" : [
      {
        "system" : "http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/pqcmc-comp-section-types",
        "code" : "32S10",
        "display" : "Substance General Information"
      }
    ]
  },
  "date" : "2023-12-15T22:19:47.022Z",
  "author" : [
    {
      "reference" : "urn:uuid:b69435a0-45c6-4d44-9fde-b354e17408d7"
    }
  ],
  "title" : "eCTD Substance General Information for levoThyroxine",
  "section" : [
    {
      "title" : "Drug Substance Nomeclature and Structure for levoThyroxine",
      "entry" : [
        {
          "reference" : "urn:uuid:21b6b724-507e-4cf4-a462-93334b98d166"
        }
      ]
    }
  ]
}